STOCK TITAN

U.S. Physical Therapy updates investor presentation

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

U.S. Physical Therapy, Inc. (USPH) updated its investor presentation on November 17, 2026. The presentation provides an overview of the company and is available under Investor Relations on its website.

Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Regulation FD Disclosure regulatory
"Regulation FD Disclosure"
Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
 
FORM 8-K
 
 
 CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): November 17, 2026
 
 U.S. PHYSICAL THERAPY, INC.
(Exact name of registrant as specified in its charter)
 
 
Nevada
 
 
001-11151
 
 
76-0364866
 
(State or other jurisdiction
of incorporation or organization)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
 
1300 WEST SAM HOUSTON PARKWAY SOUTH,
SUITE 300, HOUSTON, Texas
 
77042
 
(Address of Principal Executive Offices)
 
(Zip Code)
 
Registrant's telephone number, including area code: (713) 297-7000
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
☐
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)
 
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $.01 par value
USPH
New York Stock Exchange
Common Stock, $.01 par value
USPH
NYSE Texas, Inc.
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
                                                                                                                  Emerging growth company                                                                                                 ☐
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                                                                                                ☐
◻
 

 
ITEM 7.01 Regulation FD Disclosure
On November 17, 2026 U.S. Physical Therapy, Inc. ("the Company"),  a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, updated its investor presentation. The presentation covers an overview of the Company and is included here as Exhibit 99.1. Additionally, the presentation can be found on the Company's website at www.usph.com under the Investor Relations section.

The information in this Current Report on Form 8-K, including the exhibits, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 


 ITEM 9.01   FINANCIAL STATEMENTS AND EXHIBITS

 
Exhibit
 
Description of Exhibit
  

 

 

 
 
99.1 
 USPH Investor Presentation for the Three and Nine months ended September 30, 2026
 
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
        
    
U.S. PHYSICAL THERAPY, INC.
 
     
Dated: November 17, 2026
   
By:
 
/s/ NCHACHA ETTA
 
      
Nchacha Etta
 
      
Chief Financial Officer
 
      
(duly authorized officer and principal financial and accounting officer)
 
 
 
 
 
 
2026-11-17 U S PHYSICAL THERAPY INC /NV Common Stock, $.01 par value USPH NYSE Texas, Inc. USPH NYSETX 0000885978 false 0000885978 2026-11-05 2026-11-05 0000885978 usph:NewYorkStockExchangeMember 2026-11-05 2026-11-05 0000885978 usph:NewYorkStockExchangeMember 2026-11-05 2026-11-05 0000885978 us-gaap:CommonStockMember 2026-11-05 2026-11-05 0000885978 usph:NYSEMember 2026-11-05 2026-11-05
USPH IR Presentation FINAL.pdf page 1
USPH IR Presentation FINAL.pdf page 2
USPH IR Presentation FINAL.pdf page 3
USPH IR Presentation FINAL.pdf page 4
USPH IR Presentation FINAL.pdf page 5
USPH IR Presentation FINAL.pdf page 6
USPH IR Presentation FINAL.pdf page 7
USPH IR Presentation FINAL.pdf page 8
USPH IR Presentation FINAL.pdf page 9
USPH IR Presentation FINAL.pdf page 10
USPH IR Presentation FINAL.pdf page 11
USPH IR Presentation FINAL.pdf page 12
USPH IR Presentation FINAL.pdf page 13
USPH IR Presentation FINAL.pdf page 14
USPH IR Presentation FINAL.pdf page 15
USPH IR Presentation FINAL.pdf page 16
USPH IR Presentation FINAL.pdf page 17
USPH IR Presentation FINAL.pdf page 18
USPH IR Presentation FINAL.pdf page 19
USPH IR Presentation FINAL.pdf page 20
USPH IR Presentation FINAL.pdf page 21

Filing Exhibits & Attachments

5 documents

Keep reading